KIAA1429 has been shown to affect a variety of cancers through different pathways, including promoting the progression of hepatocellular cancer through the posttranscriptional modification of m6A relying on GATA3 and regulating cell proliferation in gastric cancer by directly targeting c-jun mRNA (62, 63). Here, VIRMA is linked to hepatocellular carcinoma.